Prescription Drug Spending

Study Finds Major Medicare Overspending Generic Prescription Drugs

by Samantha McGrail

Medicare overspent by 13.2 percent in 2017 and 20.6 percent in 2018 compared with Costco pharmacy member prices for the most commonly prescribed generic prescription drugs, according to a JAMA Network...

Medicare Prescription Drug Prices Doubled Since 2005

by Samantha McGrail

Launch prices for prescription drugs have doubled since 2005, according to researchers from Duke University’s Fuqua School of Business. David Ridley, health economist and Fuqua strategy...

GoodRx Users Save an Average $30B on Prescription Drug Costs

by Samantha McGrail

Consumers have saved nearly $30 billion on their prescription drug costs to date with prices found on the GoodRx platform, the company said in a report. In 2020, GoodRx users saved an average 79...

Aduhelm to Boost Prescription Drug Spending Over $73B by 2028

by Samantha McGrail

Biogen’s Alzheimer’s drug, Aduhelm, is expected to increase prescription drug spending and the national health expenditure more than $73 billion by 2028, according to a new Altarum...

Prescription Drug Spending Expected to Reach $400B in 2025

by Samantha McGrail

Total net prescription drug spending is expected to reach $380 billion to $400 billion in 2025, an increase from $359 billion in 2020, according to an IQVIA analysis.  This forecast is fairly...

CMS Proposes Delay of Medicaid Value-Based Payment Requirements

by Samantha McGrail

CMS recently proposed delaying Medicaid value-based drug payment requirements for state purchasing agreements with drug manufacturers until July 2022.  The rule, called “Medicaid Program...

8 Companies Claim CVS Health Overcharged for Prescription Drugs

by Samantha McGrail

Several companies are filing a lawsuit against CVS Health, claiming that the retail pharmacy chain intentionally overcharged plaintiffs for prescription drugs by submitting claims for payment at...

CVS Caremark Prescription Drug Trend Rose to 2.9% in 2020

by Samantha McGrail

CVS Caremark recently announced that its overall prescription drug trend for 2020 was 2.9 percent, while there was a negative trend for 34 percent of commercial pharmacy benefit management (PBM)...

Biden Focuses on Opioids in Prescription Drug Policy Priorities

by Samantha McGrail

The Biden Administration recently released new prescription drug policy priorities that focus on addressing the opioid epidemic and reducing drug overdoses. The priorities provide guideposts to...

GoodRx Reports Largest Uptick in Prescription Drug Prices in Years

by Samantha McGrail

In January 2020, prescription drug prices increased for 832 medications by an average of 4.6 percent, the largest increase that has occurred in years, according to a GoodRx analysis.  Of the...

US Prescription Drug Prices 256% Higher Than Other Countries

by Samantha McGrail

A recent RAND Corporation report found that prescription drug prices in the US are significantly higher than in other nations, averaging 256 percent of those seen in 32 other countries. Notably, the...

CMS Rule Allows Payers to Negotiate Prescription Drug Pricing

by Jessica Kent

CMS has issued a final rule allowing payers to negotiate prescription drug pricing based on how well these drugs work for patients, a policy that could reduce overall healthcare spending and...

Trump Issues New Rules to Lower Prescription Drug Pricing

by Samantha McGrail

President Trump recently issued two regulations to lower prescription drug pricing through a slew of new initiatives at aim prescription drug spending in Medicare.  The reforms are the direct...

Amazon Launches Its Own Pharmacy, Prescription Delivery Service

by Samantha McGrail

Amazon is moving into the pharmacy business by launching its own online pharmacy and prescription delivery services, the company recently announced. The first offering, Amazon Pharmacy, allows...

Automating Adherence Packaging Improves Medication Management

by Samantha McGrail

Medication management is crucial to improving health outcomes, especially in long-term care facilities and inpatient care settings. But packaging prescriptions for the vulnerable population can be a...

Insulin Prices 8x Higher in the US Compared to Similar Nations

by Samantha McGrail

Insulin prices are more than eight times higher in the US than in 32 comparable, high-income nations combined, according to a new RAND Corporation study. In the analysis, researchers used...

What is Medicare Part D, What Does It Mean for Pharma?

by Emily Sokol, MPH

Prescription drugs were not covered for Medicare beneficiaries prior to 2006. But the passage of the Medicare Prescription Drug, Improvement, and Modernization Act developed Medicare Part D, a voluntary prescription benefit for Medicare...

FDA Finalizes Rule on Prescription Drug Importation from Canada

by Samantha McGrail

The FDA recently finalized a rule that would allow prescription drug importation from Canada in FDA-authorized programs. The final rule, part of the White House’s Safe Importation Action Plan,...

Exploring the Most Favored Nation Approach for Drug Pricing

by Samantha McGrail

According to the White House, this strategy would allow Americans to receive the same low prices for prescription medications that are available in other countries.  But many stakeholders have...

Brand Drug Product Hopping Costs US $4.7B Annually

by Samantha McGrail

A recent analysis found that product hopping for just five brand-name drugs costs the US healthcare system $4.7 billion annually. The analysis from Matrix Global Advisors examined the effects...